266 related articles for article (PubMed ID: 20098669)
1. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.
Cencioni MT; Chiurchiù V; Catanzaro G; Borsellino G; Bernardi G; Battistini L; Maccarrone M
PLoS One; 2010 Jan; 5(1):e8688. PubMed ID: 20098669
[TBL] [Abstract][Full Text] [Related]
2. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
3. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
[TBL] [Abstract][Full Text] [Related]
4. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor.
Pucci M; Pasquariello N; Battista N; Di Tommaso M; Rapino C; Fezza F; Zuccolo M; Jourdain R; Finazzi Agrò A; Breton L; Maccarrone M
J Biol Chem; 2012 May; 287(19):15466-78. PubMed ID: 22431736
[TBL] [Abstract][Full Text] [Related]
7. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].
Liao YS; Wu J; Wang P; Zhang H
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494
[TBL] [Abstract][Full Text] [Related]
8. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis.
Pasquariello N; Catanzaro G; Marzano V; Amadio D; Barcaroli D; Oddi S; Federici G; Urbani A; Finazzi Agrò A; Maccarrone M
J Biol Chem; 2009 Oct; 284(43):29413-26. PubMed ID: 19690173
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the endocannabinoid system in periodontal healing.
Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I
Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580
[TBL] [Abstract][Full Text] [Related]
11. A putative 'pre-nervous' endocannabinoid system in early echinoderm development.
Buznikov GA; Nikitina LA; Bezuglov VV; Francisco ME; Boysen G; Obispo-Peak IN; Peterson RE; Weiss ER; Schuel H; Temple BR; Morrow AL; Lauder JM
Dev Neurosci; 2010 Mar; 32(1):1-18. PubMed ID: 19907129
[TBL] [Abstract][Full Text] [Related]
12. The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
Sharir H; Console-Bram L; Mundy C; Popoff SN; Kapur A; Abood ME
J Neuroimmune Pharmacol; 2012 Dec; 7(4):856-65. PubMed ID: 22454039
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis.
Richardson D; Pearson RG; Kurian N; Latif ML; Garle MJ; Barrett DA; Kendall DA; Scammell BE; Reeve AJ; Chapman V
Arthritis Res Ther; 2008; 10(2):R43. PubMed ID: 18416822
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.
Rajesh M; Mukhopadhyay P; Haskó G; Liaudet L; Mackie K; Pacher P
Br J Pharmacol; 2010 Jun; 160(3):688-700. PubMed ID: 20590572
[TBL] [Abstract][Full Text] [Related]
15. Endogenous cannabinoids induce fever through the activation of CB1 receptors.
Fraga D; Zanoni CI; Rae GA; Parada CA; Souza GE
Br J Pharmacol; 2009 Aug; 157(8):1494-501. PubMed ID: 19681872
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
Baldassano S; Serio R; Mule' F
Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
[TBL] [Abstract][Full Text] [Related]
17. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes.
Al Kury LT; Voitychuk OI; Ali RM; Galadari S; Yang KH; Howarth FC; Shuba YM; Oz M
Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.
Helyes Z; Németh J; Thán M; Bölcskei K; Pintér E; Szolcsányi J
Life Sci; 2003 Sep; 73(18):2345-53. PubMed ID: 12941436
[TBL] [Abstract][Full Text] [Related]
19. Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.
Eisenstein TK; Meissler JJ; Wilson Q; Gaughan JP; Adler MW
J Neuroimmunol; 2007 Sep; 189(1-2):17-22. PubMed ID: 17640739
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
